
å»åŠéèªã®èª¿æ»ã«ãããã«ããã®çè·åž«ãææ¥éå¡ã®ãã¯ã¯ãã³ãžã®ããããããé«ãå²åã§èŠãããããšã倿
å èšäºã¯ãã¡ã/Original article here
(ã©ã€ããµã€ããã¥ãŒã¹ïŒ-å°éèªã®ããŒã¿ã«ãããšãã«ããã®çè·åž«ã𿿥éå¡ã¯ãCOVID泚å°ãåããã®ãããããçãé«ãããšãããã£ãã
Blacklock's Reporterã«ãããšãå»ççŸå Žã§ã®ãã¯ã¯ãã³æ¥çš®ã®ãããããã®çºèŠã¯ã海岞ããæµ·å²žãŸã§1äž5å人ã察象ã«ãã調æ»ã®ããŒã¿ã䜿ã£ã宿åè¡ç©ã«ãããã®ã ãšããã
Canadian Medical Association Journalã®è§£èª¬ã«ãããšãããã³ãããã¯ã®åæã«ã¯ã¯ãã³ãžã®ããããã衚æããã®ã¯ãå»çåŸäºè ãæãå€ãã£ã ããšããã
åèªã¯ãçµç¹ã ãã¯ã¯ãã³æ¥çš®ã®å¥šå±ãšã¯ã¯ãã³æåŠè ã®ä¿è·ãšã®éã®ç¶±æž¡ã ããããŠããããã«èŠãããšè¿°ã¹ãŠããã
ãŸãããªã³ã¿ãªãªå·çè·åž«åäŒããã³ããã19ã®èå»¶ãé²ãããã«ã¯ã¯ãã³æ¥çš®ã ãã«é Œããªãããæè²ãã¯ã¯ãã³æ¥çš®ã®ãããããžã®å¯Ÿå¿ãæ¯æããæãå¿ èŠãªæã«çè·åž«ã眰ãããè§£éãããããªããããšãå»çåŸäºè ã«åŒ·ãæ±ããããšã玹ä»ãããŠããã
Blacklock's Reporterã«ãããšãã«ããã®å»çåŸäºè ãCOVIDãžã£ããåããããšã«æµæãããã®ã¯ãBritish Medical Journal (BMJ)ã«æ²èŒãããç ç©¶ã«åºã¥ããŠãããšã®ããšã§ãã
ããã¯ã2020幎ã®COVID屿©ã®æåã®å¹Žã«ã15,019人ã®ã«ãã人ã«questionaries'ãéããŸããããã®èª¿æ»ã¯ãã¢ã³ããªãªãŒã«è¡åå»åŠã»ã³ã¿ãŒã«äŸé Œããããã®ã§ãã
British Medical Journalã«ãããšããã¯ã¯ãã³ãããããå±éºæ§ã®é«ã2ã€ã®éèŠãªã°ã«ãŒãããã£ã ããšããããããã¯ããæ¬è³ªçãªãã®ãšå»çåŸäºè ãã§ãã£ãã
ãã®ãšãã»ã€Understanding National Trends In Covid-19 Vaccine Hesitancy In Canadaã®äžã§ãBMJã¯ãå»çåŸäºè ããŠã€ã«ã¹ã«ãããããããå¯èœæ§ãããé«ãããããå¿ é åŽåè ãšå»çåŸäºè ã®éã§ããèºèºãããšãã蚌æ ã¯ãé©ãã§ããæžå¿µææãã ãšæžããŸããã
British Medical Journalèªã¯ããã©ãã¯é転æãªã©ãå¿ é ããšãããåŽåè ã®æå€§54ïŒ ãäºé²æ¥çš®ããããã£ãŠããããšãææããã
ãã®ç ç©¶ã®èè ãã¯ããžã£ãèºèºã® ãçºèŠ ãã¯ããã«ããå å€ã®ä»ã®ç ç©¶ãšäžèŽããŠãã ããšææããã
ã«ãããããããèè ãã¯ãã©ã®ãããªã¿ã€ãã®å»çåŸäºè ã ãã¯ã¯ãã³ãããããå¯èœæ§ãé«ãã®ãããç¹å®ããããšãã§ããªãã£ããšè¿°ã¹ãŠããã
ãã®ç ç©¶ã§ã¯ã以åã®ãããŒã¿ãã§ã¯ããå»åž«ãå¥åº·ç®¡çè ããšæ¯èŒããŠãã女æ§ã®å»çåŸäºè ã ãã§ãªããçè·åž«ãææ¥éå¡ã®å°éå®¶ãã®éã§ããå€ãã®æµæãããããšã瀺åããŠããããšãææããŸããã
ãããŠãBritish Medical Journalã®ã¬ããŒãã§ã¯ããã¯ã¯ãã³ã®ãããããã¯ããã¯ã¯ãã³ã®æ°ãããšå®å šæ§ãžã®æžå¿µãã«é¢é£ããŠããå¯èœæ§ããããšè¿°ã¹ãŠããã
ã«ããã®ã»ãŒãã¹ãŠã®å·ã§ã¯ãå»çåŸäºè ã«å¯ŸããCOVIDã®çŸ©åä»ããè¡ãããŠããŸãããããªãã£ãã·ã¥ã»ã³ãã³ãã¢å·ãé€ããŠããããã®çŸ©ååã¯äžæ¢ãããããå€ãã®å·ã¯ä»ãæªæ¥çš®ã®åŽåè ã®åéçšãå¿ æ»ã§æ¢ããŠããã
å€ãã®çè·åž«, ãã®å€ãã¯ãã«ããã®ããã³ãã©ã€ã³ã®çè·åž«ã®äžéšã§ãã£ã, COVIDããã¯ããŠã³ãšãžã£ã矩åã«æè°ããããã«åœ¢æãããã°ã«ãŒã, è·å Žã®COVIDãžã£ã矩åã«å¯ŸããŠåæãã.
ããã€ãã¯æ³çãªæåãåããŠããã
å æããªã³ã¿ãªãªå·ã®ä»²è£äººã¯ãäžçµ¶ãšã®é¢é£æ§ãçç±ã«COVIDãžã£ããåããªãããšãéžæããã«ããªãã¯ã®çè·åž«ãè§£éããå ¬è¡è¡çãµãããªãŒãšå°åºãæªããšãã倿±ºãäžããã
ã¢ã«ããŒã¿å·ã¯æææ¥ãæ°å ¥ç€Ÿå¡ãåŠçãå«ãå»çåŸäºè ã«å¯ŸããCOVIDãžã£ãã®çŸ©åä»ããå šé¢çã«åãäžããã
å·æ¿åºãCOVIDãžã£ãã矩åä»ããŠããªãã«ãããããããã«ããã®é£éŠæ¿åºã¯äžè¬ã®äººã ã«å¯ŸããŠãŸã ãããæå±ããŠããã
å é±ãã«ããä¿å¥çã¯ãã¢ãã«ãã®å®éšçãªCOVID-19 mRNA泚å°ãçåŸ6ãµæã®å°å ã«æ¿èªããŸããã
仿åããã«ããã®ãžã£ã³ïŒã€ãŽã»ãã¥ã¯ãä¿å¥çžã¯ãCOVID泚å°ã¯ä»åŸã9ã«æãããšã«å¿ èŠã«ãªãã ãããšè¿°ã¹ãã
ã«ããã§ã®äœ¿çšãæ¿èªãããCOVIDãžã£ãã¯ãã¹ãŠãŸã å®éšçãªãã®ã§ãèšåºè©Šéšãå®äºããã®ã¯2023幎ã§ãã
COVIDã¯ã¯ãã³ã®çŸ©ååã¯ã«ãã瀟äŒãåè£ãããã«ããã§äœ¿çšãæ¿èªãããæ³šå°ã¯ãåã©ããã¡ã«å€æ°ã®åŠå®çã§ãã°ãã°æ·±å»ãªå¯äœçšãšé¢é£ããŠããŸãã
ãŸããäžçµ¶ãããèµ€ãåã«ç±æ¥ããçŽ°èæ ªãšã®é¢é£ãææãããŠãããâ¯ãã®çµæãå€ãã®ã«ããªãã¯æåŸããã®ä»ã®ããªã¹ãæåŸã¯ãäºé²æ¥çš®ãæåŠããŠããŸãã